219 related articles for article (PubMed ID: 27135671)
1. Evaluation of local toxic effects and outcomes for dogs undergoing marginal tumor excision with intralesional cisplatin-impregnated bead placement for treatment of soft tissue sarcomas: 62 cases (2009-2012).
Bergman NS; Urie BK; Pardo AD; Newman RG
J Am Vet Med Assoc; 2016 May; 248(10):1148-56. PubMed ID: 27135671
[TBL] [Abstract][Full Text] [Related]
2. Analysis of platinum content in biodegradable carboplatin-impregnated beads and retrospective assessment of tolerability for intralesional use of the beads in dogs following excision of subcutaneous sarcomas: 29 cases (2011-2014).
Hess TA; Drinkhouse ME; Prey JD; Miller JM; Fettig AA; Carberry CA; Brenn SH; Bailey DB
J Am Vet Med Assoc; 2018 Feb; 252(4):448-456. PubMed ID: 29393745
[TBL] [Abstract][Full Text] [Related]
3. Histologic grade predicts recurrence for marginally excised canine subcutaneous soft tissue sarcomas.
McSporran KD
Vet Pathol; 2009 Sep; 46(5):928-33. PubMed ID: 19429989
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of primary re-excision after recent inadequate resection of soft tissue sarcomas in dogs: 41 cases (1999-2004).
Bacon NJ; Dernell WS; Ehrhart N; Powers BE; Withrow SJ
J Am Vet Med Assoc; 2007 Feb; 230(4):548-54. PubMed ID: 17302554
[TBL] [Abstract][Full Text] [Related]
5. Intracavitary treatment of soft tissue sarcomas in dogs using cisplatin in a biodegradable polymer.
Dernell WS; Withrow SJ; Straw RC; Powers BE; Drekke JH; Lafferty M
Anticancer Res; 1997; 17(6D):4499-505. PubMed ID: 9494558
[TBL] [Abstract][Full Text] [Related]
6. Marginal excision of cutaneous mast cell tumors in dogs was not associated with a higher rate of complications or prolonged wound healing than marginal excision of soft tissue sarcomas.
Cockburn E; Janovec J; Solano MA; L'Eplattenier H
J Am Vet Med Assoc; 2022 Jan; 260(7):741-746. PubMed ID: 35092664
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996).
Kuntz CA; Dernell WS; Powers BE; Devitt C; Straw RC; Withrow SJ
J Am Vet Med Assoc; 1997 Nov; 211(9):1147-51. PubMed ID: 9364229
[TBL] [Abstract][Full Text] [Related]
8. Soft-tissue sarcomas in dogs: a review.
Ehrhart N
J Am Anim Hosp Assoc; 2005; 41(4):241-6. PubMed ID: 15995161
[TBL] [Abstract][Full Text] [Related]
9. Long-Term outcome following surgical excision of large, low to intermediate grade soft tissue sarcomas in dogs.
Davis A; Hosgood G
Aust Vet J; 2023 May; 101(5):193-199. PubMed ID: 36751015
[TBL] [Abstract][Full Text] [Related]
10. Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision.
Scarpa F; Sabattini S; Marconato L; Capitani O; Morini M; Bettini G
J Am Vet Med Assoc; 2012 May; 240(10):1181-7. PubMed ID: 22559107
[TBL] [Abstract][Full Text] [Related]
11. Marginal excision of low-grade spindle cell sarcoma of canine extremities: 35 dogs (1996-2006).
Stefanello D; Morello E; Roccabianca P; Iussich S; Nassuato C; Martano M; Squassino C; Avallone G; Romussi S; Buracco P
Vet Surg; 2008 Jul; 37(5):461-5. PubMed ID: 18986313
[TBL] [Abstract][Full Text] [Related]
12. Intra-operative cisplatin for the treatment of canine extremity soft tissue sarcomas.
Havlicek M; Straw RS; Langova V; Dernell WS
Vet Comp Oncol; 2009 Jun; 7(2):122-9. PubMed ID: 19453366
[TBL] [Abstract][Full Text] [Related]
13. Second intention healing after wide local excision of soft tissue sarcomas in the distal aspects of the limbs in dogs: 31 cases (2005-2012).
Prpich CY; Santamaria AC; Simcock JO; Wong HK; Nimmo JS; Kuntz CA
J Am Vet Med Assoc; 2014 Jan; 244(2):187-94. PubMed ID: 24378028
[TBL] [Abstract][Full Text] [Related]
14. Intentional marginal excision of canine limb soft tissue sarcomas followed by radiotherapy.
Demetriou JL; Brearley MJ; Constantino-Casas F; Addington C; Dobson J
J Small Anim Pract; 2012 Mar; 53(3):174-81. PubMed ID: 22931399
[TBL] [Abstract][Full Text] [Related]
15. Metronomic therapy with cyclophosphamide and piroxicam effectively delays tumor recurrence in dogs with incompletely resected soft tissue sarcomas.
Elmslie RE; Glawe P; Dow SW
J Vet Intern Med; 2008; 22(6):1373-9. PubMed ID: 18976288
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of dogs undergoing surgical resection of mast cell tumors and soft tissue sarcomas: A prospective 2-year-long study.
Milovancev M; Townsend KL; Tuohy JL; Gorman E; Bracha S; Curran KM; Russell DS
Vet Surg; 2020 Jan; 49(1):96-105. PubMed ID: 31044443
[TBL] [Abstract][Full Text] [Related]
17. Outcomes and prognostic variables associated with primary abdominal visceral soft tissue sarcomas in dogs: A Veterinary Society of Surgical Oncology retrospective study.
Linden D; Liptak JM; Vinayak A; Grimes JA; Sandey M; Smiley W; Matz BM
Vet Comp Oncol; 2019 Sep; 17(3):265-270. PubMed ID: 30666781
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiation therapy for treatment of soft tissue sarcomas in 35 dogs.
Gagnon J; Mayer MN; Belosowsky T; Mauldin GN; Waldner CL
J Am Vet Med Assoc; 2020 Jan; 256(1):102-110. PubMed ID: 31841095
[TBL] [Abstract][Full Text] [Related]
19. Scar revision for incompletely or narrowly excised soft tissue sarcomas in dogs.
Grimes JA; Rajeev M; Wallace ML; Laver T; Milovancev M
Can Vet J; 2023 Jan; 64(1):70-75. PubMed ID: 36593932
[TBL] [Abstract][Full Text] [Related]
20. Single high-dose radiation therapy and liquid fiducial markers can be used in dogs with incompletely resected soft tissue sarcomas.
Ericksen T; Mauldin N; Dickinson R; Mauldin G
J Am Vet Med Assoc; 2023 Oct; 261(10):1-8. PubMed ID: 37437890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
